within Pharmacolibrary.Drugs.ATC.G;

model G03FA09
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 0.0005833333333333334,
    adminDuration  = 600,
    adminMass      = 5 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.004,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.013333333333333334,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>G03FA09</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Noretynodrel and estrogen is a combination of noretynodrel, a first-generation synthetic progestin, and estrogen (commonly ethinylestradiol or mestranol). It was historically used as an oral contraceptive and for the treatment of menstrual disorders. This combination was among the earliest oral contraceptives introduced but is not commonly used today due to the development of safer alternatives.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for the noretynodrel and estrogen combination are not reported in the scientific literature. Parameters below are estimated based on typical values for structurally and functionally similar compounds (e.g., norethisterone, ethinylestradiol) in adult healthy female subjects.</p><h4>References</h4><ol><li><p>Adlercreutz, H, et al., &amp; Fotsis, T (1979). Steroid absorption and enterohepatic recycling. <i>Contraception</i> 20(3) 201–223. DOI:<a href=&quot;https://doi.org/10.1016/0010-7824(79)90094-5&quot;>10.1016/0010-7824(79)90094-5</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/389544/&quot;>https://pubmed.ncbi.nlm.nih.gov/389544</a></p></li><li><p>Kuhl, H (1987). [Progestagens in contraception]. <i>Wiener medizinische Wochenschrift (1946)</i> 137(18-19) 433–440. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3318155/&quot;>https://pubmed.ncbi.nlm.nih.gov/3318155</a></p></li><li><p>Orme, ML, et al., &amp; Breckenridge, AM (1983). Clinical pharmacokinetics of oral contraceptive steroids. <i>Clinical pharmacokinetics</i> 8(2) 95–136. DOI:<a href=&quot;https://doi.org/10.2165/00003088-198308020-00001&quot;>10.2165/00003088-198308020-00001</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6342899/&quot;>https://pubmed.ncbi.nlm.nih.gov/6342899</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end G03FA09;
